These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34014611)

  • 21. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.
    Zald DH; Woodward ND; Cowan RL; Riccardi P; Ansari MS; Baldwin RM; Cowan RL; Smith CE; Hakyemez H; Li R; Kessler RM
    Neuroimage; 2010 May; 51(1):53-62. PubMed ID: 20149883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
    Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
    J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
    Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
    Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain.
    Yamamoto Y; Takahata K; Kubota M; Takeuchi H; Moriguchi S; Sasaki T; Seki C; Endo H; Matsuoka K; Tagai K; Kimura Y; Kurose S; Mimura M; Kawamura K; Zhang MR; Higuchi M
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3928-3936. PubMed ID: 37581725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
    Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal and prefrontal D2R and SERT distributions contrastingly correlate with default-mode connectivity.
    Ionescu TM; Amend M; Hafiz R; Biswal BB; Maurer A; Pichler BJ; Wehrl HF; Herfert K
    Neuroimage; 2021 Nov; 243():118501. PubMed ID: 34428573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects.
    Tolboom N; Berendse HW; Leysen JE; Yaqub M; van Berckel BN; Schuit RC; Ponsen MM; Bakker E; Hoetjes NJ; Windhorst AD; Carlsson ML; Lammertsma AA; Carlsson A
    Neuropsychopharmacology; 2015 Jan; 40(2):472-9. PubMed ID: 25248987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between dopamine transporter density measured by
    Maekawa T; Sato N; Ota M; Sugiyama A; Sone D; Enokizono M; Kimura Y; Mukai Y; Murata M; Takano H; Imabayashi E; Matsuda H; Kunimatsu A; Abe O
    Jpn J Radiol; 2017 Dec; 35(12):755-759. PubMed ID: 29063467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography.
    Ito H; Takahashi H; Arakawa R; Takano H; Suhara T
    Neuroimage; 2008 Jan; 39(2):555-65. PubMed ID: 17962043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Thanos PK; Logan J; Alexoff D; Ding YS; Wong C; Ma Y; Pradhan K
    Neuroimage; 2008 Oct; 42(4):1537-43. PubMed ID: 18598772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
    Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
    Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum.
    Cervenka S; Bäckman L; Cselényi Z; Halldin C; Farde L
    Neuroimage; 2008 Apr; 40(3):1287-95. PubMed ID: 18296072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral grey matter density is associated with neuroreceptor and neurotransporter availability: A combined PET and MRI study.
    Manninen S; Karjalainen T; Tuominen LJ; Hietala J; Kaasinen V; Joutsa J; Rinne J; Nummenmaa L
    Neuroimage; 2021 Jul; 235():117968. PubMed ID: 33785434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
    Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
    Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accentuated Paralimbic and Reduced Mesolimbic D
    Stark AJ; Song AK; Petersen KJ; Hay KR; Lin YC; Trujillo P; Kang H; Collazzo JM; Donahue MJ; Zald DH; Claassen DO
    J Neurosci; 2023 Dec; 43(50):8733-8743. PubMed ID: 37852792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.
    Caravaggio F; Raitsin S; Gerretsen P; Nakajima S; Wilson A; Graff-Guerrero A
    Biol Psychiatry; 2015 Jan; 77(2):196-202. PubMed ID: 23540907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding.
    Sambataro F; Fazio L; Taurisano P; Gelao B; Porcelli A; Mancini M; Sinibaldi L; Ursini G; Masellis R; Caforio G; Di Giorgio A; Niccoli-Asabella A; Popolizio T; Blasi G; Bertolino A
    Schizophr Bull; 2013 Jan; 39(1):206-16. PubMed ID: 21976709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans.
    Bertolino A; Fazio L; Di Giorgio A; Blasi G; Romano R; Taurisano P; Caforio G; Sinibaldi L; Ursini G; Popolizio T; Tirotta E; Papp A; Dallapiccola B; Borrelli E; Sadee W
    J Neurosci; 2009 Jan; 29(4):1224-34. PubMed ID: 19176830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.